Trial · NCT07364227
Anterior vs Posterior vs Combined Intra-Articular Injections for Adhesive Capsulitis
NCT07364227, Not applicable, Not yet recruiting, Aslinur Keles Ercisli, MD, PhD
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Anterior vs Posterior vs Combined Intra-Articular Injections for Adhesive Capsulitis. Trials, record NCT07364227. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07364227
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Anterior vs Posterior vs Combined Intra-Articular Injections for Adhesive Capsulitis
- NCT number
- NCT07364227
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 30 participants, estimated
- Lead sponsor
- Aslinur Keles Ercisli, MD, PhD
- Conditions
- Adhesive Capsulitis of the Shoulder, Intra Articular Injection
- Interventions
- Intervention Name: Posterior Intra-articular Injection, Anterior Intra-articular Injection, Combined Anterior + Posterior Intra-articular Injection
- First posted
- 2026-01-23
- Last updated
- 2026-01-23
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Shoulder Range of Motion (ROM) | Baseline, immediately post-injection, week 3, week 6, week 12 | Change in active and passive shoulder joint range of motion (flexion, extension, abduction, external rotation, internal rotation) measured with a goniometer. |
| Secondary | Change in Pain Intensity (NRS) | Baseline, immediately post-injection, week 3, week 6, week 12 | Number Rating Scale (0-10) for pain at rest, during activity, and at night. |
| Secondary | Subjective Shoulder Value (SSV) | Baseline, immediately post-injection, week 3, week 6, week 12 | Patient's self-reported percentage of normal shoulder function (0-100%). |
| Secondary | Shoulder Pain and Disability Index (SPADI) | Baseline, week 3, week 6, week 12 | Questionnaire assessing pain and disability (0-100 score, higher scores = worse function). |
| Secondary | Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) | Baseline, week 3, week 6, week 12 | Questionnaire measuring upper limb disability and symptoms (0-100 score, higher = worse). |
| Secondary | American Shoulder and Elbow Surgeons (ASES) Score | Baseline, week 3, week 6, week 12 | Composite score including pain and function (0-100, higher = better). |
| Secondary | Constant-Murley Shoulder Score | Baseline, week 3, week 6, week 12 | Clinical score combining pain, activities of daily living, strength, and ROM (0-100). |
| Secondary | Scratch Test Score | Baseline, immediately post-injection, week 3, week 6, week 12 | Functional test measuring the patient's ability to reach behind the back. |
| Secondary | Axillary Capsule Thickness (Ultrasound) | Baseline, immediately post-injection (only). | Ultrasound measurement of axillary recess capsule thickness on the affected shoulder. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07364227
GET https://conductscience.org/api/trials/v1/NCT07364227/registered